Dpp8 selective inhibitor tominostat as a novel and broad-spectrum anticancer agent against hematological malignancies

HIGHLIGHTS

  • who: Shohei Kikuchi and collaborators from the Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, Sugitani, Toyama, Japan have published the research work: DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies, in the Journal: Cells 2023, 12, x FOR PEER REVIEW of 29/03/2023
  • what: In view of these contradictory findings, the authors conducted the studies described in this paper to further investigate 1G244-induced cell death. The authors named this 12 m molecule tominostat and performed the experiments described below. The authors inhibitor . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?